Alessandra Bartolozzi

This inventor holds 21 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Surface Logix, Inc., Axial Therapeutics, Inc.. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessandra Bartolozzi. Retrieved from https://idiyas.com/inventor/alessandra-bartolozzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 122(Granted Patents)

Location History:

Somerville, MA (US) (2013 - 2020)
Norwalk, CT (US) (2011 - 2022)

Company Filing History:

14 out of 1,562

Boehringer Ingelheim International Gmbh

Axial Therapeutics, Inc.

patents

Years Active: 2011-2022

Loading Chart...

Areas of Expertise:

Amyloid Inhibitors

Pharmacokinetics

CB2 Receptor

Leukotriene Production

Heterocyclic Compounds

Oxadiazole Inhibitors

Microsomal Triglyceride Transfer

Therapeutic Applications

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11505528 - Inhibitors of microbially induced amyloid (2022-11-22),

2. 10570123 - Pharmacokinetically improved compounds (2020-02-25),

3. 9656960 - Inhibitors of microsomal triglyceride transfer protein and apo-B secretion (2017-05-23),

4. 9440961 - Rho-kinase inhibitors and method of preparation (2016-09-13),

5. 9315454 - Compounds which modulate the CB2 receptor (2016-04-19),

6. 9174980 - Heterocyclic compounds as inhibitors of leukotriene production (2015-11-03),

7. 8980915 - Inhibitors of microsomal triglyceride transfer protein and apo-B secretion (2015-03-17),

8. 8916576 - Pharmacokinetically improved compounds (2014-12-23),

9. 8889670 - Heterocyclic compounds which modulate the CB2 receptor (2014-11-18),

10. 8735430 - Compounds which selectively modulate the CB2 receptor (2014-05-27),

11. 8658661 - Oxadiazole inhibitors of leukotriene production (2014-02-25),

12. 8580829 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

13. 8580825 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

14. 8575201 - Oxadiazole inhibitors of leukotriene production (2013-11-05),

15. 8383651 - Compounds which selectively modulate the CB2 receptor (2013-02-26),

Title: The Innovative Journey of Alessandra Bartolozzi

Introduction: Alessandra Bartolozzi, a pioneering inventor hailing from Norwalk, CT, has made significant contributions to the world of technology and innovation with her groundbreaking ideas and inventions.

Latest Patents: Alessandra Bartolozzi's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution for urban environments.

Career Highlights: With a background in electrical engineering and a passion for creating solutions that improve everyday life, Alessandra Bartolozzi has garnered recognition for her innovative spirit. Throughout her career, she has received multiple awards for her inventions and has been featured in various tech publications for her forward-thinking approach.

Collaborations: Alessandra Bartolozzi has collaborated with leading tech companies to bring her inventions to life, working closely with engineers and designers to ensure that her ideas are translated into practical and user-friendly products. Her collaborative efforts have resulted in successful product launches and widespread acclaim in the industry.

Conclusion: Alessandra Bartolozzi's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the field of technology. Her inventive spirit continues to inspire others to push the boundaries of what is possible, shaping the future of technology for generations to come.

Profile summary based on public USPTO records.